| Charles Kang, MD | |
|
650 Huebner Rd, Fort Riley, KS 66442-4030 | |
| (785) 239-7000 | |
| Not Available |
| Full Name | Charles Kang |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 650 Huebner Rd, Fort Riley, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457711707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0101263205 (Virginia) | Secondary |
| 208000000X | Pediatrics | 0101263205 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Kang, MD 650 Huebner Rd, Fort Riley, KS 66442-4030 Ph: () - | Charles Kang, MD 650 Huebner Rd, Fort Riley, KS 66442-4030 Ph: (785) 239-7000 |
News Archive
In a paper featured in Proceedings of the National Academy of Science (PNAS), researchers from Boston University School of Dental Medicine report the discovery of a new gene, STAT6(B), that helps regulate production of the potentially deadly tumor necrosis factor alpha (TNF-alpha) cytokine.
Federal regulators have approved a state plan to pay hospitals an additional $87 million this year for the care they provide to low-income Ohioans on Medicaid. The funds will be disbursed to hospitals by the end of this month. The bulk payment and a 5 percent increase in Medicaid reimbursement fees effective in October were included in last year's state budget to let hospitals recoup some of the money they were losing through a new state franchise fee. The fee is projected to cost hospitals statewide $718 million over the two-year budget ending June 30, 2011.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.
› Verified 2 days ago
Giathinh Cat Ngo, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 714-240-7206 | |
Dr. Kathleen Marie O'brien, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-785-2397 Fax: 630-570-5779 | |
Nickolas Kondiles, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-3627 |